
ImmuneBridge
Developer of allogeneic cellular immunotherapies designed for advancing cancer treatment. The company's immunotherapies utilize proprietary expansion technology to amplify cord blood-derived immune st...
Valuation
$11M
Latest known
Share Price
N/A
Total Raised
$17.6M
Last Round
N/A